Search Results - "Gingell, R."

Clinical experience of scoring criteria for Familial Hypercholesterolaemia (FH) genetic testing in Wales by Haralambos, K, Whatley, S.D, Edwards, R, Gingell, R, Townsend, D, Ashfield-Watt, P, Lansberg, P, Datta, D.B.N, McDowell, I.F.W

“…Abstract Background/Objective Familial Hypercholesterolaemia (FH) is caused by mutations in genes of the Low Density Lipoprotein (LDL) receptor pathway. A…”
Get full text

Searching for the elusive familial hypercholesterolaemia gene mutations for index patients – using historical laboratory LDL-c results in primary care. A North Wales experience by Teoh, Y.P, Gingell, R

Get full text

Evolocumab & Inclisiran dual therapy for further LDL lowering in a very high cardiovascular risk Familial Hypercholesterolaemia patient with heterozygous gain of function PCSK9 mutation by Gingell, R., Das, P., Teoh, Y.P.

Get full text

Familial hypercholesterolaemia - geomapping of the baseline LDL levels and characterisation of LDL receptor mutations for patients diagnosed in the North Wales screening programme 2010–2015 by De Soysa, M, Gingell, R, Teoh, Y.P

Get full text

Development of an e-learning program on Familial Hypercholesterolaemia (FH) for primary care by Edwards R, R, Gingell, R, Townsend, D, Lewis, N, Datta, D, McDowell, I.F.W

Get full text

Relationship between measurements of non-HDL-cholesterol and LDL-cholesterol in Familial Hypercholesterolaemia by Abreu, J, Haralambos, K, Ashfield-Watt, P, Edwards, R, Gingell, R, Townsend, D, Datta, D, McDowell, I.F.W

Get full text

Web based tools to assess eligibility for genetic testing for Familial Hypercholesterolaemia (FH) by Ashfield-Watt, P.A.L, Haralambos, K, Sharif, B, Edwards, R, Gingell, R, Townsend, D, Datta, D, McDowell, I.F.W

Get full text

Optimising detection and management of Familial Hypercholesterolaemia (FH) – Revision of the FH Audit tool to monitor lipid levels by Green, P, Payne, J, Humphries, S.E, Neely, D, Gingell, R, Lunken, C, Oliver, G, Boley, S, Helm, R

Get full text

Five year experience of scoring criteria for familial hypercholesterolaemia (FH) genetic testing in wales: Should the criteria be refined to include age? by Haralambos, K, Ashfield-Watt, P, Edwards, R, Gingell, R, Townsend, D, Whatley, S.D, Datta, D.B.N, McDowell, I.F.W

Get full text

GENETIC VARIANTS OF UNCERTAIN SIGNIFICANCE (VUS) IN FAMILIAL HYPERCHOLESTEROLAEMIA (FH) IN WALES: YEAR 2 UPDATE by Haralambos, K, Whatley, S.D, Edwards, R, Gingell, R, Townsend, D, Holmans, P, Clarke, A, Datta, D.B.N, Butler, R, Palmer-Smith, S, Wood, M, McDowell, I.F.W

Get full text

Implementation of a multidisciplinary approach to diagnosis and management of familial hypercholesterolaemia (FH) in Wales: The role of the FH specialist nurse by Edwards, R, Townsend, D, Gingell, R, Haralambos, K, Datta, B.N, McDowell, I.F.W, Edmunds, L

Get full text

Genetic variants of uncertain significance (VUS) in familial hypercholesterolaemia (FH): Can family based association studies help determine pathogenicity? by Haralambos, K, Whatley, S.D, Edwards, R, Gingell, R, Townsend, D, Holmans, P, Clarke, A, Datta, B.N, McDowell, I.F.W

Get full text

Familial hypercholesterolaemia (FH) in Wales is genetically heterogeneous by Haralambos, K, Whatley, S.D, Datta, B.N, Townsend, D, Gingell, R, Edwards, R, Lansberg, P, Graham, C, Palacios, L, Dean, P, McDowell, I.F.W

Get full text

Implementation of familial hypercholesterolaemia(FH) nurse led assessment clinics in South Wales by Edwards, R, El Farhan, N, Woods, S, Hopcroft, H, Townsend, D, Gingell, R, Haralambos, K, Datta, B.N, McDowell, I.F.W, Edmunds, L

Get full text

(9) Evaluation of genotype scoring criteria for familial hypercholesterolaemia (FH) in wales by Haralambos, K, Whatley, S, Datta, D, Townsend, D, Gingell, R, Edwards, R, Williams, J, Lansberg, P, Mc Dowell, I

Get full text

Methyl isobutyl ketone (MIBK) induction of alpha 2u-globulin nephropathy in male, but not female rats by Borghoff, S J, Hard, G C, Berdasco, N M, Gingell, R, Green, S M, Gulledge, W

“…Male F-344 rats were administered corn oil (vehicle control), d-limonene (positive control, 300mg/kg), or MIBK (1000mg/kg) and female F-344 rats corn oil…”
Get full text

Methyl isobutyl ketone (MIBK) induction of α2u-globulin nephropathy in male, but not female rats by Borghoff, S.J, Hard, G.C, Berdasco, N.M, Gingell, R, Green, S.M, Gulledge, W

“…Abstract Male F-344 rats were administered corn oil (vehicle control), d-limonene (positive control, 300 mg/kg), or MIBK (1000 mg/kg) and female F-344 rats…”
Get full text

Dual therapy with inclisiran and evolocumab in a heterozygous FH patient while on maximum statin and ezetimibe dose to achieve LDL targets by Gingell, R., Das, P., Teoh, Y.P.

Get full text

Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity by Corley, R.A., Wilson, D.M., Hard, G.C., Stebbins, K.E., Bartels, M.J., Soelberg, J.J., Dryzga, M.D., Gingell, R., McMartin, K.E., Snellings, W.M.

“…Male Wistar rats have been shown to be the most sensitive sex, strain and species to ethylene glycol-induced nephrotoxicity in subchronic studies. A chronic…”
Get full text

Neurodevelopmental outcome of infants with hypoplastic left heart syndrome by Rogers, B.T., Msall, M.E., Buck, G.M., Lyon, N.R., Norris, M.K., Roland, J.-M.A., Gingell, R.L., Cleveland, D.C., Pieroni, D.R.

“…The neurodevelopmental outcome of hypoplastic left heart syndrome in infants remains unclear. All 11 survivors of staged surgical repair of hypoplastic left…”
Get full text